June 05th, 2023

On Thursday, June 8, several companies are expected to report their financial results, including: DocuSign, Inc. (Nasdaq: DOCU), a prominent electronic signature and digital transaction management company, is scheduled to release its first quarter. Read more

June 05th, 2023

On Wednesday, June 7, several companies are anticipated to release their financial results, including: Verint Systems Inc. (Nasdaq: VRNT), a leading provider of customer engagement solutions, is set to announce its first quarter fiscal 2024 financ. Read more

June 04th, 2023

AstraZeneca's (Nasdaq: AZN) announced that TAGRISSO (osimertinib) has demonstrated a significant improvement in overall survival (OS) in patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC).&nb. Read more

June 04th, 2023

On Wednesday, June 7, several companies are set to release their financial results, providing insights into their performance and market trends. Trip.com Group Limited (Nasdaq: TCOM), a leading online travel services provider, will announce its fi. Read more

June 04th, 2023

Raytheon Missiles and Defense, one of four business segments of Raytheon Technologies Corporation (NYSE: RTX), has been awarded a modification contract worth $263,717,654.  This modification exercises options for the production and delivery o. Read more

June 04th, 2023

A range of companies is set to announce their financial results on Tuesday, June 6, offering insights into their performance and market dynamics. Stitch Fix, Inc. (Nasdaq: SFIX), an online personal styling service, will release its third-quarter f. Read more

June 04th, 2023

Several companies are expected to report their financial results on Tuesday, June 6, providing insights into their performance and market trends. Hello Group Inc. (Nasdaq: MOMO), a leading social networking platform, will release its unaudited fin. Read more

June 04th, 2023

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) released the comprehensive findings from the ROSE2 Phase 2 clinical trial, which examined the efficacy of obicetrapib, their oral, low-dose cholesteryl ester transfer protein inhibitor, in conjunction w. Read more

June 04th, 2023

Several companies are set to release their financial results on Tuesday, June 6, including: Academy Sports and Outdoors, Inc. (Nasdaq: ASO), a leading sporting goods and outdoor recreation retailer, is set to announce its first-quarter fiscal 2023. Read more

June 04th, 2023

Evaxion Biotech A/S (Nasdaq: EVAX) announced encouraging findings from its EVX-01 Phase 1 clinical trial, which assessed the safety and effectiveness of EVX-01 in combination with a checkpoint inhibitor for metastatic melanoma patients.  Acco. Read more